- Home
- OSTX vs KROS Comparison
OSTX vs KROS Comparison
Compare OSTX & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSTX
- KROS
- Stock Information
- Founded
- OSTX 2018
- KROS 2015
- Country
- OSTX United States
- KROS United States
- Employees
- OSTX N/A
- KROS N/A
- Industry
- OSTX
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- OSTX
- KROS Health Care
- Exchange
- OSTX NYSE
- KROS Nasdaq
- Market Cap
- OSTX 45.0M
- KROS N/A
- IPO Year
- OSTX 2024
- KROS 2020
- Fundamental
- Price
- OSTX $1.53
- KROS $14.15
- Analyst Decision
- OSTX Strong Buy
- KROS Buy
- Analyst Count
- OSTX 3
- KROS 12
- Target Price
- OSTX $18.00
- KROS $21.00
- AVG Volume (30 Days)
- OSTX 345.0K
- KROS 720.2K
- Earning Date
- OSTX 05-16-2025
- KROS 05-06-2025
- Dividend Yield
- OSTX N/A
- KROS N/A
- EPS Growth
- OSTX N/A
- KROS N/A
- EPS
- OSTX N/A
- KROS 0.11
- Revenue
- OSTX N/A
- KROS $214,713,000.00
- Revenue This Year
- OSTX N/A
- KROS $706.85
- Revenue Next Year
- OSTX N/A
- KROS N/A
- P/E Ratio
- OSTX N/A
- KROS $129.86
- Revenue Growth
- OSTX N/A
- KROS 91657.70
- 52 Week Low
- OSTX $1.12
- KROS $9.12
- 52 Week High
- OSTX $7.00
- KROS $72.37
- Technical
- Relative Strength Index (RSI)
- OSTX N/A
- KROS 54.47
- Support Level
- OSTX N/A
- KROS $13.72
- Resistance Level
- OSTX N/A
- KROS $14.91
- Average True Range (ATR)
- OSTX 0.00
- KROS 0.56
- MACD
- OSTX 0.00
- KROS -0.06
- Stochastic Oscillator
- OSTX 0.00
- KROS 57.16
About OSTX OS THERAPIES INCORPORATED
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the need for new treatments in cancers of the bone in children and young adults.